USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Biotech Research Laboratory
Address:
3 Taft Court
Rockville, MD 20850
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $365,596.00 6
SBIR Phase II $2,303,682.00 5

Award List:

POROUS MICROCARRIERS FOR GROWING CELL CULTURES

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Anton F. Steuer , Principal Investigator
Abstract:
N/a

USE OF NONISOTOPIC DNA PROBE FOR DETECTION OF VIRAL NUCLEIC

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$35,569.00
Agency:
HHS
Principal Investigator:
Mark M. Manak , Principal Investigator
Abstract:
N/a

USE OF NONISOTOPIC DNA PROBE FOR DETECTION OF VIRAL NUCLEIC

Award Year / Program / Phase:
1986 / SBIR / Phase II
Award Amount:
$390,000.00
Agency:
HHS
Principal Investigator:
Mark M. Manak , Principal Investigator
Abstract:
Biotech has developed a system for labeling dna fragments with hapten-modified ""tails'' which can be detected by immunological methods using enzyme-conjugated antibodies. the detection sensitivity of this system is 274 picogram, which is sufficient to detect single copy genes in human dna. the aim… More

POROUS MICROCARRIERS FOR GROWING CELL CULTURES

Award Year / Program / Phase:
1987 / SBIR / Phase II
Award Amount:
$242,000.00
Agency:
HHS
Principal Investigator:
Anton F. Steuer , Principal Investigator
Abstract:
The overall objective of this program is to develop cost-effective technology for the scale-up of mammalian cell culture for the manufacture of products such as monoclonal antibodies or genetically engineered proteins. the approach involves growth of cells in the interstices of a porous matrix,… More

USE OF PCR FOR DIAGNOSING HIV-1 INFECTION IN PEDIATRIC PATIENTS

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$49,999.00
Agency:
HHS
Principal Investigator:
Mark M Manak
Abstract:
N/a

USE OF PCR FOR DIAGNOSING HIV-1 INFECTION IN PEDIATRIC PATIENTS

Award Year / Program / Phase:
1992 / SBIR / Phase II
Award Amount:
$381,682.00
Agency:
HHS
Principal Investigator:
Mark M Manak
Abstract:
Prevalence studies for hiv-1 infection in newborns are difficult to obtain because the commonly used antibody assays are not appropriate for testing babies. babies carrythe maternal antibody for up to 12 to 18 months after birth,so all babies born to seropositive mothers will also test positive. yet… More

Simple, Rapid PCR Based Assay for Lyme Borreliosis

Award Year / Program / Phase:
1992 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

Quant. Of HCV RNA Using a DNA Capture Assay

Award Year / Program / Phase:
1994 / SBIR / Phase I
Award Amount:
$80,236.00
Agency:
HHS
Principal Investigator:
Irene Gonzalez
Abstract:
A simple, inexpensive and reliable format amendable for testing large numbers of clinical samplesfor the presence of HCV RNA will be developed in the course of this contract. The conditions for samplecollection, storage and processing will be carefully controlled to ensure maximum reproducibility… More

Simple, Rapid PCR Based Assay for Lyme Borreliosis

Award Year / Program / Phase:
1994 / SBIR / Phase II
Award Amount:
$540,000.00
Agency:
HHS
Principal Investigator:
Abstract:
N/a

Multiplex RT-PCR Test for HTLV-I/II, HIV-1, HBV and HCV

Award Year / Program / Phase:
1995 / SBIR / Phase I
Award Amount:
$99,792.00
Agency:
HHS
Principal Investigator:
Lucia Gonzalez-Villasenor
Abstract:
N/a

Multiplex RT-PCR Test for HTLV-I/II, HIV-1, HBV and HCV

Award Year / Program / Phase:
1997 / SBIR / Phase II
Award Amount:
$750,000.00
Agency:
HHS
Principal Investigator:
Lucia Gonzalez-Villasenor
Abstract:
A novel, unique, rapid and reliable multiplex RT-PCR test will be developed for the simultaneous deviral pathogens, HTLV- I/II, HIV-1, HBV and HCV, frequently associated with transfusion- transmittedtranscription of HCV RNA, and amplification of HTLV-I/ II, HIV-1 and HBV DNAs will be carried out… More